Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "central"

837 News Found

Biocon appoints Karthik SM as Head HR for India, Malaysia and Emerging Markets
People | April 15, 2026

Biocon appoints Karthik SM as Head HR for India, Malaysia and Emerging Markets

In his new role, Karthik will lead human capital strategy and HR operations across these regions


Oxford-ZEISS advances breakthrough live-cell imaging platform for next-gen drug discovery
R&D | April 15, 2026

Oxford-ZEISS advances breakthrough live-cell imaging platform for next-gen drug discovery

The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners


Bisleri expands CSR support for rural mental health programme in MP
Healthcare | April 15, 2026

Bisleri expands CSR support for rural mental health programme in MP

Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district


MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price
Drug Approval | April 15, 2026

MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price

CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing


MedLern partners with Godrej Memorial Hospital to strengthen accreditation-led workforce training
Hospitals | April 15, 2026

MedLern partners with Godrej Memorial Hospital to strengthen accreditation-led workforce training

Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes


CDSCO invites bids for next-gen Digital Drugs Regulatory System
Drug Approval | April 15, 2026

CDSCO invites bids for next-gen Digital Drugs Regulatory System

API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India


Boehringer Ingelheim & BioNTech launch high-stakes lung cancer combo trial
Clinical Trials | April 14, 2026

Boehringer Ingelheim & BioNTech launch high-stakes lung cancer combo trial

BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study


Briefs: Indoco Remedies and Panacea Biotec
News | April 14, 2026

Briefs: Indoco Remedies and Panacea Biotec

Panacea Biotec receives LoA from CMSS


CDSCO reforms cut trial approval timelines by over 50%: DCGI Dr Rajeev Raghuvanshi
Drug Approval | April 14, 2026

CDSCO reforms cut trial approval timelines by over 50%: DCGI Dr Rajeev Raghuvanshi

Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews


Why secure, empathetic home care defines the next era of healthcare delivery: Suhasini Deshmukh, Co-founder, MedRabbits
Opinion | April 14, 2026

Why secure, empathetic home care defines the next era of healthcare delivery: Suhasini Deshmukh, Co-founder, MedRabbits

Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs